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Abstract The immunohistochemical analysis of the distribution
of 5-oxo-L-prolinase in porcine brain at the light microscopic
level was performed with an antibody raised against the enzyme
purified from pig kidney. The present study reveals the specific
expression of 5-oxo-L-prolinase in brain capillaries with an
average diameter of 4.1 þ 0.9 Wm, while larger blood vessels
remain unstained. Porcine kidney and skeletal muscle show no
endothelial-specific staining with the antibody. In some cases, the
asymmetrical staining pattern in cross and longitudinal sections
of brain microvessels indicate endothelial- but also pericyte-
specific expression.
z 1999 Federation of European Biochemical Societies.
Key words: 5-Oxo-L-prolinase; Q-Glutamyl cycle;
Blood-brain barrier; Brain microvessel endothelial cell ;
Pericyte; Amino acid transport
1. Introduction
In most vertebrates, homoeostasis of the brain is main-
tained by the blood-brain barrier (BBB), a regulatory inter-
face localized in the continuous layer of brain microvessel
endothelial cells (BMECs) [1,2].
A commonly used marker of the BBB is Q-glutamyl trans-
peptidase (GGT: EC 2.3.2.2), an enzyme not found in the
endothelium of peripheral tissues. In organs such as liver
and kidney, GGT plays a role in amino acid transport, me-
tabolism of leukotrienes and conversion of toxic substances to
mercapturic acids [3]. When GGT expression was shown in
brain capillaries, it was initially proposed that the enzyme
might participate in the delivery of amino acids into the cen-
tral nervous system via the Q-glutamyl cycle [4]. In more recent
studies, GGT was mainly found in abluminal membranes of
BMECs and microcapillary associated pericytes [5,6] and was
described to contribute to pericytes’ ability to act as a second
line of defense catabolizing brain-borne leukotriene C4 [7].
Interestingly, species-dependent di¡erences in the localization
of GGT at the blood-brain interface were observed [8]. The
enzyme was present on the luminal surface of endothelial cells
in rats, whereas in mouse, monkey and human cortex, GGT
was found in astrocytic endfeet around the vessels. The au-
thors concluded that in the latter case, GGT from astrocytes
may play a role in the detoxication of lipophilic xenobiotics
that cross the endothelial barrier [8].
The amino acid transport hypothesis was supported by Lee
and coworkers [9], who demonstrated that 5-oxo-L-proline, an
intermediate of the Q-glutamyl cycle and the substrate of
5-oxo-L-prolinase (5-OPase), acts as a second messenger mol-
ecule, stimulating the amino acid transport across the BBB via
the A- and B0-system. Still, the presence of 5-OPase or other
enzymes of the Q-glutamyl cycle apart from GGT have not
been investigated by direct immunohistochemical methods at
the BBB, although of 5-OPase activity has already been
shown at the choroid plexus, locus of the barrier between
blood and liquor cerebrospinalis [10] and more recently in
brain capillaries and BMECs [11].
The present study was conducted to further elucidate the
role of GGT and to support the idea of the Q-glutamyl cycle at
the BBB by investigating the expression of 5-OPase in porcine
brain. An antiserum raised against 5-OPase from porcine kid-
ney supports the ¢nding that 5-OPase is localized in brain
microcapillaries, endothelial cells as well as in pericytes but
not in peripheral microvessels.
2. Materials and methods
2.1. Enzyme puri¢cation and preparation of antibodies
5-OPase was partially puri¢ed from porcine kidney according to
[12] with some minor modi¢cations. After size exclusion chromatog-
raphy, the sample containing 5-OPase activity was subjected to prep-
arative SDS-PAGE with subsequent Coomassie-staining. The 5-OPase
band (140 kDa) was cut out and the protein recovered by electro-
elution and precipitation [13]. Rabbit antibodies were generated by
Eurogentec (Seraing, Belgium). Isolation of IgGs from the antiserum
was performed according to Harboe and Ingild [14]. The IgGs recog-
nized a 140 kDa band in crude kidney lysate together with a 50 kDa
signal caused by cross-reactivity with porcine IgGs. Cross-reactive
antibodies were removed by incubation of the antibody-solution
with powdered nitrocellulose coated with porcine IgGs [15]. Non-
bound immunoglobulins merely contained 5-OPase-speci¢c antibodies
and were used for immunohistochemical studies.
2.2. Immunohistochemical staining
Small tissue cubes from porcine cerebrum, cerebellum, kidney and
skeletal muscle were ¢xed in 4% paraformaldehyde/PBS. For 5-OPase-
speci¢c staining, para⁄n sections (10 Wm) were used. After removal of
para⁄n, defatting, permeabilization and rehydration, proteins were
denatured with SDS in PBS (1 g/100 ml). SDS was removed by three
washes with PBS. Blocking was carried out with bovine serum albu-
min in PBS (3 g/100 ml). The bu¡ered primary antibody solution
contained 400 Wg/ml a⁄nity-puri¢ed rabbit anti-5-OPase IgG and ad-
ditionally 1.4 mg/ml heat denaturated IgGs from pig serum. Secondary
antibody binding was performed with a 1:200 dilution of biotin-
labelled goat anti-rabbit IgG (Sigma, St. Louis, MO, USA) in PBS
with 1 g/100 ml bovine serum albumin. The sections were then stained
with a streptavidin-phycoerythrin staining kit (Amersham Buchler,
Braunschweig) as recommended by the manufacturer. Reference sec-
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tions were treated with preimmune serum diluted to approximately
3.7 mg IgG/ml with PBS containing 0.4 mg/ml bovine serum albumin.
Cryo-sections (10 Wm) were used in experiments with the laminin
antiserum. Laminin-speci¢c staining was carried out with an antise-
rum (rabbit) generated against mouse laminin with cross-reactivity
towards porcine laminin (R. Deutzmann, Regensburg). IgG concen-
tration of the laminin antiserum was 10 Wg/ml, PBS containing 0.4 mg
bovine serum albumin/ml during the primary antibody binding. In
these cases, secondary antibody binding was performed with a Texas-
Red-labelled goat anti-rabbit IgG (Vector Lab., Burlingame), 15
Wg/ml in PBS containing 1 g/100 ml bovine serum albumin.
3. Results
In order to analyze 5-OPase distribution in porcine cere-
brum and cerebellum, we prepared tissue sections from for-
malin-¢xed, para⁄n-embedded porcine brain. Since the anti-
body was raised against SDS-treated 5-OPase, pretreatment of
all tissue slices with the detergent was evident to obtain sig-
ni¢cant staining. Indirect immuno£uorescence staining
showed 5-OPase localization especially in smaller vessels of
brain cortex and cerebellum, whereas larger vessels remain
unstained (Fig. 1A, B). The inner diameter of 5-OPase pos-
itive vessels ranges from 3.0 to 5.2 Wm, with an average of
4.1 þ 0.9 Wm. A narrow band of staining surrounds the micro-
vessels. In some cases, cross and longitudinal sections of capil-
laries showed an asymmetrical staining. Control sections
treated with preimmune serum remain unstained (Fig. 1C).
Comparative studies with an anti-laminin antiserum showed
an overall staining of capillaries, as well as larger vessels, due
to the occurrence of laminin in all basement membranes (Fig.
1D).
When examining porcine kidney, strongest immunoreactiv-
ity against 5-OPase was observed in proximal tubules (Fig.
1E), whereas glomeruli and blood vessels remained unstained.
In order to demonstrate that peripheral microvessels lack
5-OPase, slides of skeletal muscle were also investigated. As
shown in Fig. 1F, only a di¡use background staining was
obtained.
4. Discussion
Since GGT has been detected in brain capillaries [16], the
enzyme was regarded as a BBB marker enzyme. In peripheral
tissues, such as kidney, GGT is expressed by the epithelium of
proximal tubules [17] but not in blood vessels. Orlowski and
coworkers [4] postulated that GGT in brain tissues may be
involved in amino acid transport via the Q-glutamyl cycle.
However, GGT participates also in detoxicative pathways
(mercapturic acid pathway and leukotriene metabolism). Con-
sequently, the sole fact that GGT occurs in brain capillaries
does not demonstrate the occurence of the Q-glutamyl cycle at
the BBB.
To prove that the Q-glutamyl cycle is present in brain micro-
capillaries, we have chosen another enzyme of this pathway,
5-OPase. The immunohistochemical study in pig tissues pre-
sented here showed vessel-speci¢c staining only in cortex and
cerebellum. Calculated from the inner diameter, those vessels
can be regarded as capillaries. In particular cases, cross and
longitudinal sections of capillaries seem to have asymmetrical
staining pattern that could be due to the expression of the
enzyme in pericytes.
Our data therefore support the amino acid transport hy-
pothesis via the Q-glutamyl cycle at the BBB. We also con-
clude that 5-OPase can be regarded as a new BBB marker,
due to its absence in peripheral vessels of skeletal muscle and
kidney. Even though the localization of 5-OPase in pericytes
remains to be elucidated by electron microcopy, the staining
pattern at the light microscopic level seems to be similar to
that of GGT in porcine brain [5].
Although GGT has been under investigation at the BBB for
several decades, the localization of the enzyme in brain micro-
vessel constituting cell types was under controversial discus-
sion, as well as the occurence on luminal or abluminal mem-
branes [5,18,19]. More recently, species di¡erences have been
demonstrated for both brain barrier tissues, brain capillaries
and plexus chorioideus [8,20]. Interestingly, Zlokovic et al.
could not ¢nd any GGT-mediated degradation of glutathione
on the luminal side of perfused brain microvessels [21], which
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Fig. 1. A: microvessels of pig cerebellum stained with the puri¢ed
anti-5-OPase antibody. B: anti-5-OPase positive microvessels of pig
cortex. C: control sections of pig cerebellum treated with the preim-
mune serum showed a weak background staining of Purkinje neu-
rons. D: immunoreactivity for anti-laminin (mouse) demonstrates
the overall staining of all blood vessels, even larger than microcapil-
laries. E: tissue section of pig kidney stained with the a⁄nity puri-
¢ed anti-5-OPase antibody, displaying illuminated tubular structures
but not glomerular or any other blood vessels. F: the lack of any
5-OPase-speci¢c staining in skeletal muscle emphasizes that the en-
zyme is not expressed by endothelial cells of peripheral blood ves-
sels. The staining procedure was carried out as given in Section 2.
All micrographs were taken from 10 Wm sections of para⁄n-em-
bedded tissue (5-OPase) or cryosections (laminin) from porcine
brain. 1 Bar = 10 Wm.
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gives indirect evidence for a non-luminal orientation of the
enzyme.
Lee et al. [9] proposed a model for the action of the Q-
glutamyl cycle by following the idea of a luminal localization
of GGT. They hypothesized that the enzyme uses blood-borne
substrates to produce Q-glutamyl amino acids which subse-
quently enter the brain endothelium and are converted into
free amino acids and 5-oxo-L-proline. As shown in their study,
this metabolite is able to activate the B0- and A-system for
amino acid transport at the abluminal membrane of endothe-
lial cells. 5-OPase therefore plays a crucial role within this
pathway at the BBB by degrading the transport-stimulating
molecule.
In view of the data presented in our study, together with the
abluminal orientation of GGT in porcine brain microvessels
[5,6], the regulation of retrograde transport of neurotransmit-
ter amino acids by the Q-glutamyl cycle should also be con-
sidered.
However, 5-OPase activity in the brain capillaries may not
only be due to the occurence of the Q-glutamyl cycle in this
tissue. Cerebral 5-oxo-L-proline is additionally produced e.g.
by the degradation of certain neuropeptides [22] and must be
removed from the brain due to its neuromodulatory and toxic
properties [23,24].
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